Feng et al. (2020) concluded that gender, BRAF V600E mutation, CLT, tumor size, specific tumor location, intraoperative detected ETE and BMI were independent risk factors for ipsilateral or contralateral CLNM in patients with PTCI, based on which a nomogram was constructed to assess the risk of developing CLNM in patients with PTCI. The gene discussed is BRAF; the disease is neoplasm.